|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye
QH, Wang L, Zhou J, Qiu SJ, Li Y, et al: A decade's studies on
metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol.
130:187–196. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Donovan P and Poronnik P: Nedd4 and
Nedd4-2: Ubiquitin ligases at work in the neuron. Int J Biochem
Cell Biol. 45:706–710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kerscher O, Felberbaum R and Hochstrasser
M: Modification of proteins by ubiquitin and ubiquitin-like
proteins. Annu Rev Cell Dev Biol. 22:159–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar S, Tomooka Y and Noda M:
Identification of a set of genes with developmentally
down-regulated expression in the mouse brain. Biochem Biophys Res
Commun. 185:1155–1161. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakayama KI and Nakayama K: Ubiquitin
ligases: Cell-cycle control and cancer. Nat Rev Cancer. 6:369–381.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen C and Matesic LE: The Nedd4-like
family of E3 ubiquitin ligases and cancer. Cancer Metastasis Rev.
26:587–604. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bellet MM, Piobbico D, Bartoli D, Castelli
M, Pieroni S, Brunacci C, Chiacchiaretta M, Del Sordo R, Fallarino
F, Sidoni A, et al: NEDD4 controls the expression of GUCD1, a
protein upregulated in proliferating liver cells. Cell Cycle.
13:1902–1911. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baker SJ: PTEN enters the nuclear age.
Cell. 128:25–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eide PW, Cekaite L, Danielsen SA,
Eilertsen IA, Kjenseth A, Fykerud TA, Ågesen TH, Bruun J, Rivedal
E, Lothe RA and Leithe E: NEDD4 is overexpressed in colorectal
cancer and promotes colonic cell growth independently of the
PI3K/PTEN/AKT pathway. Cell Signal. 25:12–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G,
Zeng Y, Sun B, Qian H, Chen L, et al: MicroRNA-21 suppresses PTEN
and hSulf-1 expression and promotes hepatocellular carcinoma
progression through AKT/ERK pathways. Cancer Lett. 337:226–236.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and epidemiology of hepatocellular
carcinoma: A global and regional perspective. Oncologist. 15:(Suppl
4). 5–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bosch FX, Ribes J, Díaz M and Cléries R:
Primary liver cancer: Worldwide incidence and trends.
Gastroenterology. 127:(5 Suppl 1). 5–16. 2004. View Article : Google Scholar
|
|
18
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuen MF, Hou JL and Chutaputti A: Asia
Pacific Working Party on Prevention of Hepatocellular Carcinoma:
Hepatocellular carcinoma in the Asia pacific region. J
Gastroenterol Hepatol. 24:346–353. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mann CD, Neal CP, Garcea G, Manson MM,
Dennison AR and Berry DP: Prognostic molecular markers in
hepatocellular carcinoma: A systematic review. Eur J Cancer.
43:979–992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okano H, Nakajima H, Tochio T, Suga D,
Kumazawa H, Isono Y, Tanaka H, Matsusaki S, Sase T, Saito T, et al:
A case of a resectable single hepatic epithelioid
hemangioendothelioma with characteristic imaging by ADC map. Clin J
Gastroentero. 8:406–413. 2015. View Article : Google Scholar
|
|
22
|
Zhao YJ, Ju Q and Li GC: Tumor markers for
hepatocellular carcinoma. Mol Clin Oncol. 1:593–598.
2013.PubMed/NCBI
|
|
23
|
Sakata T, Sakaguchi H, Tsuda L,
Higashitani A, Aigaki T, Matsuno K and Hayashi S: Drosophila Nedd4
regulates endocytosis of notch and suppresses its
ligand-independent activation. Curr Biol. 14:2228–2236. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Amodio N, Scrima M, Palaia L, Salman AN,
Quintiero A, Franco R, Botti G, Pirozzi P, Rocco G, De Rosa N and
Viglietto G: Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a
PTEN negative regulator, in non-small-cell lung carcinomas. Am J
Pathol. 177:2622–2634. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao C, Pang L, Ren C and Ma T: Decreased
expression of Nedd4L correlates with poor prognosis in gastric
cancer patient. Med Oncol. 29:1733–1738. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He S, Deng J, Li G, Wang B, Cao Y and Tu
Y: Down-regulation of Nedd4L is associated with the aggressive
progression and worse prognosis of malignant glioma. Jpn J Clin
Oncol. 42:196–201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao CJ, Chi HC, Tsai CY, Chen CD, Wu SM,
Tseng YH, Lin YH, Chung IH, Chen CY, Lin SL, et al: A novel
small-form NEDD4 regulates cell invasiveness and apoptosis to
promote tumor metastasis. Oncotarget. 6:9341–9354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakashita H, Inoue H, Akamine S, Ishida T,
Inase N, Shirao K, Mori M and Mimori K: Identification of the
NEDD4L gene as a prognostic marker by integrated microarray
analysis of copy number and gene expression profiling in non-small
cell lung cancer. Ann Surg Oncol. 20:(Suppl 3). 590–598. 2013.
View Article : Google Scholar
|
